Please login to the form below

Not currently logged in
Email:
Password:

Evista

This page shows the latest Evista news and features for those working in and with pharma, biotech and healthcare.

Lilly’s president and chief executive John Lechleiter to retire

Lilly’s president and chief executive John Lechleiter to retire

Sales of blockbuster lung cancer treatment Alimta (pemetrexed disodium) have suffered with UK and German courts ruling in favour of the generic competition, while patents for Lilly's osteoporosis drug Evista

Latest news

More from news
Approximately 2 fully matching, plus 23 partially matching documents found.

Latest from PMHub

  • Maximising ROI from mature brands

    News that Eli Lilly and Co has forecast a drop in 2014 profits and reduced its sales outlook because of generic competition to its Cymbalta antidepressant and Evista drug for osteoporosis,

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...
MIT reveals new pill to deliver insulin
A new MIT research project, sponsored by Novo Nordisk, is aiming to deliver insulin orally with a pill that releases medicine in the stomach lining. Dina Patel interviews the team...
Fearless Girl cover
25 Women Leaders in UK Healthcare
Women trailblazers helping to shape the future of healthcare (Part 1)...

Infographics